The usefulness of AI in the medical field? Artificial intelligence (AI) is transforming healthcare. Its applications are steadily expanding, from diagnostic imaging to new drug development and personalized treatment recommendations. However, alongside the positive changes brought by this technological advancement, ethical challenges that we must seriously consider are also emerging. A recent MIT Technology Review report, 'AI, Ushering in a New Era of Medicine: From Diagnosis to Drug Discovery,' presented the revolutionary changes AI technology will bring to the medical field with specific examples and technical data. According to this report, AI can analyze medical images and identify lesions in seconds, a task that would manually take hours or even days. The report specifically highlights that AI-powered diagnostic imaging systems are significantly contributing to the early detection of intractable diseases such as breast and lung cancer. The lead researchers of the report emphasize, 'AI technology is demonstrating accuracy similar to, or sometimes even surpassing, human experts in analyzing cancer diagnostic images.' Indeed, several studies have reported cases where AI systems detected specific cancers with over 90% accuracy. Furthermore, AI also possesses the ability to analyze patient genetic data and formulate personalized treatment plans. In the field of genomics, AI excels at processing vast amounts of genetic information and identifying gene mutations associated with specific diseases. AI's role in new drug development is also noteworthy. MIT Technology Review reports that AI is dramatically shortening the compound screening process. In traditional drug development, it takes an average of over 10 years and billions of dollars to bring a single new drug to market. However, by utilizing AI technology, the initial stage of identifying promising drug candidates can be significantly accelerated. The report cites examples where some pharmaceutical companies have reduced the time for discovering new drug candidates by more than half compared to traditional methods through AI. Robotic surgery is also benefiting from AI technology. AI-assisted robotic surgery systems compensate for surgeon tremors and enable more precise operations by recognizing anatomical structures in real-time during surgery. This contributes to shortening patient recovery times and reducing the risk of complications. In Korea, the adoption of such AI medical technologies is also gradually expanding. Major tertiary hospitals like Seoul National University Hospital, Samsung Medical Center, and Asan Medical Center have introduced AI-based diagnostic imaging assistance systems to support radiologists' interpretations. Specifically, AI systems are being utilized in areas such as lung nodule detection, breast cancer screening, and cerebral hemorrhage detection. The Ministry of Food and Drug Safety has approved numerous AI-based medical devices since 2020, and that number continues to grow. However, technological advancement does not always bring only positive effects. A study from LSE (London School of Economics) Blogs, 'Ethics of AI in Healthcare: Data Privacy, Bias, and Accountability,' deeply illuminates the various ethical and social challenges accompanying the development of AI medical technology. Data privacy is one of the most critical ethical challenges facing AI medical technology. LSE Blogs researchers point out, 'Medical AI systems inherently have a high potential for privacy infringement because they collect and analyze individuals' health data in great detail.' Medical data is among an individual's most sensitive information, including genetic information, medical history, and lifestyle habits. Serious harm can occur if such data is leaked or misused. The study warns that medical data breaches are indeed increasing globally. Cases of sensitive health information being exposed through various channels such as hacking, insider leaks, and system errors are being reported. Particularly, the risk increases if privacy protection measures are insufficient during the process of collecting and sharing large amounts of data for AI system development. In Korea, laws such as the Personal Information Protection Act and the Bioethics and Safety Act regulate medical data protection, but there are criticisms that legal regulations are not keeping pace with the rapid development of AI technology. While the revision of the Data 3 Laws has allowed the use of pseudonymized information, concerns still exist regarding the risk of re-identification and the transparency of consent procedures. The issue of algorithmic bias is also serious. LSE Blogs research warns, 'AI algorithms can reflect, or even amplify, the biases present in the data used for training.' If certain racial, gender, or age groups are under- or over-represented in the training data, the AI system may provide inaccurate or unfair diagnoses and treatments for these groups. Data-Driven Te
Related Articles